Literature DB >> 9364046

Expression of neuroserpin, an inhibitor of tissue plasminogen activator, in the developing and adult nervous system of the mouse.

S R Krueger1, G P Ghisu, P Cinelli, T P Gschwend, T Osterwalder, D P Wolfer, P Sonderegger.   

Abstract

Neuroserpin is a serine protease inhibitor of the serpin family that has been identified as an axonally secreted glycoprotein in neuronal cultures of chicken dorsal root ganglia. To obtain an indication for possible functions of neuroserpin, we analyzed its expression in the developing and the adult CNS of the mouse. In the adult CNS, neuroserpin was most strongly expressed in the neocortex, the hippocampal formation, the olfactory bulb, and the amygdala. In contrast, most thalamic nuclei, the caudate putamen, and the cerebellar granule cells were devoid of neuroserpin mRNA. During embryonic development, neuroserpin mRNA was not detectable in neuroepithelia, but it was expressed in the differentiating fields of most CNS regions concurrent with their appearance. In the cerebellum, the granule cells and a subgroup of Purkinje cells were neuroserpin-positive during postnatal development. As a further step toward the elucidation of neuroserpin function, we performed a study to identify potential target proteases. In vitro, neuroserpin formed SDS-stable complexes and inhibited the amidolytic activity of tissue plasminogen activator, urokinase, and plasmin. In contrast, no complex formation with or inhibition of thrombin was found. Expression pattern and inhibitory specificity implicate neuroserpin as a candidate regulator of plasminogen activators, which have been suggested to participate in the modulation or reorganization of synaptic connections in the adult. During development, neuroserpin may attenuate extracellular proteolysis related to processes such as neuronal migration, axogenesis, or the formation of mature synaptic connections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9364046      PMCID: PMC6573583     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  54 in total

Review 1.  Horizontal integration and cortical dynamics.

Authors:  C D Gilbert
Journal:  Neuron       Date:  1992-07       Impact factor: 17.173

Review 2.  An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.

Authors:  M Kozak
Journal:  Nucleic Acids Res       Date:  1987-10-26       Impact factor: 16.971

Review 3.  Cortical plasticity and memory.

Authors:  M M Merzenich; K Sameshima
Journal:  Curr Opin Neurobiol       Date:  1993-04       Impact factor: 6.627

4.  Patterns of amino acids near signal-sequence cleavage sites.

Authors:  G von Heijne
Journal:  Eur J Biochem       Date:  1983-06-01

5.  Signal sequences. The limits of variation.

Authors:  G von Heijne
Journal:  J Mol Biol       Date:  1985-07-05       Impact factor: 5.469

6.  Neuroserpin, an axonally secreted serine protease inhibitor.

Authors:  T Osterwalder; J Contartese; E T Stoeckli; T B Kuhn; P Sonderegger
Journal:  EMBO J       Date:  1996-06-17       Impact factor: 11.598

7.  Overexpression of urokinase-type plasminogen activator in transgenic mice is correlated with impaired learning.

Authors:  N Meiri; T Masos; K Rosenblum; R Miskin; Y Dudai
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

8.  A different form of long-lasting potentiation revealed in tissue plasminogen activator mutant mice.

Authors:  U Frey; M Müller; D Kuhl
Journal:  J Neurosci       Date:  1996-03-15       Impact factor: 6.167

9.  Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction.

Authors:  Y Liu; R D Fields; B W Festoff; P G Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

10.  Peripheral neurons and Schwann cells secrete plasminogen activator.

Authors:  A Krystosek; N W Seeds
Journal:  J Cell Biol       Date:  1984-02       Impact factor: 10.539

View more
  42 in total

1.  Accumulation of mutant neuroserpin precedes development of clinical symptoms in familial encephalopathy with neuroserpin inclusion bodies.

Authors:  Giovanna Galliciotti; Markus Glatzel; Jochen Kinter; Serguei V Kozlov; Paolo Cinelli; Thomas Rülicke; Peter Sonderegger
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

2.  Neuroserpin is expressed in the pituitary and adrenal glands and induces the extension of neurite-like processes in AtT-20 cells.

Authors:  R M Hill; P K Parmar; L C Coates; E Mezey; J F Pearson; N P Birch
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

3.  HuD binds to three AU-rich sequences in the 3'-UTR of neuroserpin mRNA and promotes the accumulation of neuroserpin mRNA and protein.

Authors:  Ana Cuadrado; Cristina Navarro-Yubero; Henry Furneaux; Jochen Kinter; Peter Sonderegger; Alberto Muñoz
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

4.  Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains.

Authors:  M D Ledesma; J S Da Silva; K Crassaerts; A Delacourte; B De Strooper; C G Dotti
Journal:  EMBO Rep       Date:  2000-12       Impact factor: 8.807

5.  Biochemical characterization of a neuroserpin variant associated with hereditary dementia.

Authors:  M Yazaki; J J Liepnieks; J R Murrell; M Takao; B Guenther; P Piccardo; M R Farlow; B Ghetti; M D Benson
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

6.  Potentiation of NMDA receptor function by the serine protease thrombin.

Authors:  M B Gingrich; C E Junge; P Lyuboslavsky; S F Traynelis
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

Review 7.  Serine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behavior.

Authors:  Antoine G Almonte; J David Sweatt
Journal:  Brain Res       Date:  2011-06-24       Impact factor: 3.252

8.  pH-dependent stability of neuroserpin is mediated by histidines 119 and 138; implications for the control of beta-sheet A and polymerization.

Authors:  Didier Belorgey; Peter Hägglöf; Maki Onda; David A Lomas
Journal:  Protein Sci       Date:  2010-02       Impact factor: 6.725

Review 9.  Tissue-type plasminogen activator as a therapeutic target in stroke.

Authors:  Iordanis Gravanis; Stella E Tsirka
Journal:  Expert Opin Ther Targets       Date:  2008-02       Impact factor: 6.902

10.  Probing neuroserpin polymerization and interaction with amyloid-beta peptides using single molecule fluorescence.

Authors:  Albert Chiou; Peter Hägglöf; Angel Orte; Allen Yuyin Chen; Paul D Dunne; Didier Belorgey; Susanna Karlsson-Li; David A Lomas; David Klenerman
Journal:  Biophys J       Date:  2009-10-21       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.